Helixa Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth 57.33%
- Profit Growth -75.18%
- Ebitda -29.84%
- Net Worth 19.05%
- Total Assets -13.35%
About Helixa Lifesciences
Helixa Lifesciences Private Limited (HLPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 30 October 2017 (Seven years and four months 13 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Viplav Lakshmisathyanarayana, Sravani Doddala, Doddala Mahadev, and One other member serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999TG2017PTC120315
- Company No.
120315
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Oct 2017
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Life Sciences
Helixa Lifesciences Private Limited
Explore comprehensive data for Helixa Lifesciences Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Helixa Lifesciences?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Viplav Lakshmisathyanarayana  | Director | 30-Oct-2017 | Current |
| Sravani Doddala | Director | 07-Apr-2020 | Current |
| Doddala Mahadev | Director | 30-Oct-2017 | Current |
| Venu Sudheer | Director | 19-Feb-2018 | Current |
Financial Performance of Helixa Lifesciences.
Helixa Lifesciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 57.33% increase. The company also saw a substantial fall in profitability, with a 75.18% decrease in profit. The company's net worth Soared by an impressive increase of 19.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Helixa Lifesciences?
In 2018, Helixa Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Nuronics Labs Private LimitedViplav Lakshmisathyanarayana is a mutual person
Fastronix Private LimitedViplav Lakshmisathyanarayana and Venu Sudheer are mutual person
- Xyz Innovations Private Limited
Viplav Lakshmisathyanarayana is a mutual person
- Thinkgreen Impex Private Limited
Viplav Lakshmisathyanarayana and Sravani Doddala are mutual person
- Ycs Gryll Cafe Private Limited
Sravani Doddala is a mutual person
- Triumph Fibernet Private Limited
Venu Sudheer is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Helixa Lifesciences?
Unlock and access historical data on people associated with Helixa Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Helixa Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Helixa Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Helixa Lifesciences
Recent activity within the organization
- Annual General Meeting
Helixa Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
- Balance Sheet
Helixa Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad.
- Director Appointment
Sravani Doddala was appointed as a Director was appointed as a Director on 07 Apr 2020 & has been associated with this company since 4 years 11 months .
- Director Appointment
Venu Kathineedi Sudheer was appointed as a Director was appointed as a Director on 19 Feb 2018 & has been associated with this company since 7 years 22 days .
- Director Appointment
Viplav Kumar Valluri Lakshmisathyanarayana was appointed as a Director was appointed as a Director on 30 Oct 2017 & has been associated with this company since 7 years 4 months .
- Director Appointment
Doddala Sankara Mahadev was appointed as a Director was appointed as a Director on 30 Oct 2017 & has been associated with this company since 7 years 4 months .
Frequently asked questions
What is the Incorporation or founding date of Helixa Lifesciences Private Limited?
Helixa Lifesciences Private Limited was incorporated on 30 Oct 2017.
What is authorized share capital and paid-up capital of Helixa Lifesciences Private Limited?
The authorized share capital of Helixa Lifesciences Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Who are the current board members & directors of Helixa Lifesciences Private Limited?
Currently 4 directors are associated with Helixa Lifesciences Private Limited.
- Viplav Kumar Valluri Lakshmisathyanarayana
- Sravani Doddala
- Doddala Sankara Mahadev
- Venu Kathineedi Sudheer
What is the registered address of Helixa Lifesciences Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Helixa Lifesciences Private Limited is 202 10-2-298/86 Pritinadita Residency, Shanti Nagar India, Hyderabad, Telangana, 500028.
What is the corporate identification number (CIN) and company number of Helixa Lifesciences Private Limited?
The corporate identification number (CIN) of Helixa Lifesciences Private Limited is U74999TG2017PTC120315 and the company number is 120315 as per Ministry of Corporate Affairs (MCA).
What is the official website of Helixa Lifesciences Private Limited?
The Official website of Helixa Lifesciences Private Limited is https://www.helixa.org
What has been the recent revenue trend for Helixa Lifesciences Private Limited?
According to the financial reports for the fiscal year 2020, the revenue trend for Helixa Lifesciences Private Limited has risen by 57.33%.
What change has been observed in the net worth of Helixa Lifesciences Private Limited, and by what percentage?
The financial reports for the fiscal year 2020 indicates that The net worth of Helixa Lifesciences Private Limited has experienced an upsurge of 19.05%.
When was the last Balance Sheet of Helixa Lifesciences Private Limited filed with the ROC?
The most recent Balance Sheet for Helixa Lifesciences Private Limited was filed with the ROC on 31 Mar 2022.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records